GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States) (Q64123586)

From Wikidata
Revision as of 02:56, 25 August 2024 by MidleadingBot (talk | contribs) (‎Changed label, description and/or aliases in zh, zh-hans, zh-hant, ca, ru, ja, ko, es: bot (details))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
clinical trial

    Statements

    title
    GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States) (English)
    0 references
    country
    Austria
    0 references
    Belgium
    0 references
    Bulgaria
    0 references
    Croatia
    0 references
    Denmark
    0 references
    Estonia
    0 references
    France
    0 references
    Germany
    0 references
    Greece
    0 references
    Ireland
    0 references
    Italy
    0 references
    Latvia
    0 references
    Netherlands
    0 references
    Norway
    0 references
    Poland
    0 references
    Portugal
    0 references
    Romania
    0 references
    Slovenia
    0 references
    Spain
    0 references
    Sweden
    0 references
    United Kingdom
    0 references
    start time
    22 August 2012
    0 references
    end time
    31 December 2019
    0 references
    number of participants
    17,789
    0 references
    minimum age
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q64123586&oldid=2235449180"